Literature DB >> 11030717

Evidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladder.

M Tognetto1, M Trevisani, B Maggiore, G Navarra, A Turini, R Guerrini, N W Bunnett, P Geppetti, S Harrison.   

Abstract

We have investigated the ability of protease-activated receptor-1 (PAR-1), PAR-2, PAR-3 and PAR-4 agonists to induce contractile responses in isolated guinea-pig gallbladder. Thrombin, trypsin, mouse PAR-1 activating (SFLLRN-NH(2)) peptide, and mouse PAR-2 activating (SLIGRL-NH(2)) and human PAR-2 activating (SLIGKV-NH(2)) peptides produced a concentration-dependent contractile response. Mouse PAR-4 activating (GYPGKF-NH(2)) peptide, the mouse PAR-1 reverse (NRLLFS-NH(2)) peptide, the mouse PAR-2 reverse (LRGILS-NH(2)) and human PAR-2 reverse (VKGILS-NH(2)) peptides caused negligible contractile responses at the highest concentrations tested. An additive effect was observed following the contractile response induced by either trypsin or thrombin, with the addition of a different PAR agonist (SFLLRN-NH(2) and SLIGRL-NH(2), respectively). Desensitization to PAR-2 activating peptide attenuated the response to trypsin but failed to attenuate the response to PAR-1 agonists, and conversely desensitization to PAR-1 attenuated the response to thrombin but failed to alter contractile responses to PAR-2 agonists. The contractile responses produced by thrombin, trypsin, SFLLRN-NH(2) and SLIGRL-NH(2) were markedly reduced in the presence of the cyclo-oxygenase inhibitor, indomethacin, whilst the small contractile response produced by NRLLFS-NH(2) and LRGILS-NH(2) were insensitive to indomethacin. The contractile responses to thrombin, trypsin, SFLLRN-NH(2) and SLIGRL-NH(2) were unaffected by the presence of: the non-selective muscarinic antagonist, atropine; the nitric oxide synthase inhibitor, L-NAME; the sodium channel blocker, tetrodotoxin; the combination of selective tachykinin NK(1) and NK(2) receptor antagonists, (S)-1-[2-[3-(3,4-dichlorphenyl)-1 (3-isopropoxyphenylacetyl) piperidin-3-yl] ethyl]-4-phenyl-1 azaniabicyclo [2.2.2] octane chloride (SR140333) and (S)-N-methyl-N-[4-acetylamino-4-phenylpiperidino-2-(3, 4-dichlorophenyl)-butyl] benzamide (SR48968), respectively. The results indicate that PAR-1 and PAR-2 activation causes contractile responses in the guinea-pig gallbladder, an effect that is mediated principally by prostanoid release, and is independent of neural mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030717      PMCID: PMC1572377          DOI: 10.1038/sj.bjp.0703618

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.

Authors:  M D Hollenberg; M Saifeddine; B al-Ani; A Kawabata
Journal:  Can J Physiol Pharmacol       Date:  1997-07       Impact factor: 2.273

2.  Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study.

Authors:  E A Akriviadis; M Hatzigavriel; D Kapnias; J Kirimlidis; A Markantas; A Garyfallos
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

Review 3.  Protease-mediated signalling: new paradigms for cell regulation and drug development.

Authors:  M D Hollenberg
Journal:  Trends Pharmacol Sci       Date:  1996-01       Impact factor: 14.819

4.  Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo.

Authors:  W M Cheung; P Andrade-Gordon; C K Derian; B P Damiano
Journal:  Can J Physiol Pharmacol       Date:  1998-01       Impact factor: 2.273

5.  Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2.

Authors:  C U Corvera; O Déry; K McConalogue; S K Böhm; L M Khitin; G H Caughey; D G Payan; N W Bunnett
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

7.  Ligand cross-reactivity within the protease-activated receptor family.

Authors:  B D Blackhart; K Emilsson; D Nguyen; W Teng; A J Martelli; S Nystedt; J Sundelin; R M Scarborough
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

8.  Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.

Authors:  R Patacchini; L Barthó; C A Maggi
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

9.  Cloning and characterization of human protease-activated receptor 4.

Authors:  W F Xu; H Andersen; T E Whitmore; S R Presnell; D P Yee; A Ching; T Gilbert; E W Davie; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.

Authors:  J R Hamilton; P B Nguyen; T M Cocks
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

View more
  4 in total

Review 1.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

2.  Dual effect mediated by protease-activated receptors on the mechanical activity of rat colon.

Authors:  Flavia Mulè; Maria Carmela Baffi; Maria Carmela Cerra
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

3.  Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon.

Authors:  F Mulè; R Pizzuti; A Capparelli; N Vergnolle
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

4.  Small Intestine Protection of Mica Against Non-Steroidal Anti-Inflammatory Drugs-Injury Through ERK1/2 Signal Pathway in Rats.

Authors:  Shuo Zhang; Yinghua He; Zheng Shi; Jianping Jiang; Beihui He; Sumei Xu; Zhengyu Fang
Journal:  Front Pharmacol       Date:  2019-08-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.